N-Nitroso Nilotinib
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

2925306-68-7N-Nitroso Nilotinib

● Under Development

Catalogue No.:VE0011411
CAS No.:2925306-68-7
Mol. Formula:C28H21F3N8O2
Mol. Weight:558.53 g/mol

Additional information on CAS 2925306-68-7

Parent drug

Nilotinib

IUPAC Name

4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(nitroso(4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide

Pharmacopeial Synonyms

N/A

Synonyms

N-Nitroso Nilotinib Impurity 1

Smiles

O=C(NC1=CC(C(F)(F)F)=CC(N2C=C(C)N=C2)=C1)C3=CC=C(C)C(N(N=O)C4=NC=CC(C5=CC=CN=C5)=N4)=C3

InChI

InChI=1S/C28H21F3N8O2/c1-17-5-6-19(10-25(17)39(37-41)27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(40)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,40)

Description

N-Nitroso Nilotinib (CAS 2925306-68-7), also designated N-Nitroso Nilotinib Impurity 1, is a nitrosamine-related process impurity of the tyrosine kinase inhibitor nilotinib. With molecular formula C28H21F3N8O2 and molecular weight 558.53 g/mol, it contains an N-nitroso functionality superimposed on the highly substituted heteroaromatic scaffold, consistent with nitrosation arising during synthesis or from exposure of amine precursors to nitrosating agents. As a potential genotoxic impurity, it falls within the risk-based assessment framework associated with ICH M7. Reliable characterization generally requires LC-MS/MS for trace-level quantification, supported by high-resolution MS and, where feasible, orthogonal LC-UV or GC-MS confirmation.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url